Emerg Infect Dis by Al Hammoud, Roukaya et al.
Leone); staff (nurses, physicians, pharmacists, logisticians,  
administrators, cleaners, drivers, cooks, guards) at the  
Emergency Ebola Treatment Center (Goderich, Freetown,  
Sierra Leone) and the Emergency Surgical and Pediatric  
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Infection with Angiostrongylus cantonensis roundworms is en-
demic in Southeast Asia and the Pacific Basin. A. cantonensis 
meningitis and myelitis occurred in summer 2013 in a child with 
no history of travel outside of Texas, USA. Angiostrongyliasis 
is an emerging neurotropic helminthic disease in Texas and 
warrants increased awareness among healthcare providers.
In summer 2013, a previously healthy Caucasian 12-month-old girl was brought for treatment to a chil-
dren’s hospital in Houston, Texas, USA, on the 11th day 
of illness (day 11), manifesting intermittent fever, lethargy, 
and emesis. She had been evaluated by a pediatrician on 
day 3 and diagnosed with presumed viral infection. She at-
tended day care, had no history of sick contacts, and apart 
from dogs in the house, had no notable other exposures. 
At hospital admission, physical examination showed 
vital signs within reference ranges, mild distress, lethargy, 
and irritability with no focal deficits or signs of meningeal 
irritation. Blood test results showed leukocytosis (17,900 
cells/mm3 with 20% eosinophils). Cerebrospinal fluid 
(CSF) examination showed 8 erythrocytes and 568 leuko-
cytes/mm3 with 26% eosinophils. Results of bacterial cul-
tures and PCR of CSF for herpes simplex virus and entero-
virus were negative. She had no serologic evidence of acute 
infection with West Nile virus or HIV. Magnetic resonance 
imaging (MRI) of the brain showed normal results. She re-
ceived ceftriaxone, vancomycin, and acyclovir from days 
11 through 15 with no clinical improvement. 
On day 16, because the child had been exposed to dogs, 
she was empirically treated for presumed Toxocara infec-
tion with albendazole and prednisone for 5 days. Her clinical 
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condition improved. However, 2 days after she completed 
the albendazole and prednisone regimen (day 23), fever and 
lethargy recurred, she was unable to bear weight, and CSF 
analysis showed increased eosinophilia (1,500 leukocytes/
mm3 with 35% eosinophils). On day 23, MRI showed diffuse 
leptomeningeal enhancement in the brain and spinal cord, 
diffuse punctate areas of cortical infarction, and intramedul-
lary enhancement (Figure). On the same day, she was again 
treated with albendazole and prednisone with good response. 
Results of serologic testing performed at the hospital 
were negative for Trichinella, Toxocara, and Schistosoma 
spp. Serum and CSF samples were sent to the Centers for 
Diseases Control and Prevention (Atlanta, GA, USA); 
PCR results showed CSF was positive for Angiostrongylus 
cantonensis, and serum was positive for Toxocara Stron-
gyloides stercoralis IgG. On day 31, we diagnosed A. can-
tonensis meningitis and myelitis with cross-reactions to 
S. stercoralis and Toxocara spp. The patient completed 2 
weeks of albendazole therapy (from day 23 through day 
37) and 3 months of prednisone therapy with slow tapering. 
The patient’s symptoms completely resolved by day 64. 
Lumbar punctures on days 35, 56, and 104 showed gradual 
return of CSF parameters to normal ranges. On day 56, re-
sults of an MRI of the brain were unremarkable. 
The case was reported to the local health department, 
which tested snails trapped close to the patient’s residence. 
No evidence of A. cantonensis roundworms was found.
In 1987, A. cantonensis roundworm was identified for 
the first time in North America in rodents. (1). Although a 
PCR-based assay did not detect A. cantonensis roundworm 
in samples of intermediate hosts (snails) in Houston, Texas, 
the parasite has been repeatedly identified in southeastern 
and Gulf states (Louisiana, Oklahoma, Mississippi, Florida) 
(2,3). In parallel, human infections have increased. The first 
reported human case of A. cantonensis meningitis in a non-
traveler in the contiguous United States occurred in 1995 in 
a 10-year-old boy in New Orleans, Louisiana, who had eaten 
raw snails (4). Since the case we report, 2 additional cases in 
children were reported in Houston, in the spring of 2016 (5). 
The frequency of A. cantonensis infections in humans 
is likely underreported due to a combination of factors, in-
cluding the frequent self-limited course of the infection, 
lack of awareness of the parasite, limited availability of 
diagnostic testing, and lack of national surveillance. Al-
though the disease usually resolves spontaneously, case-fa-
tality rates can reach 5% (6). Lack of clinical suspicion for 
angiostrongyliasis on the basis of signs and symptoms and 
delay in initiation of treatment can lead to neurologic dete-
rioration, especially in young children, as demonstrated in 
our patient and another report (7). 
In conclusion, angiostrongyliasis is an emerging neu-
rotropic helminthic disease in Texas. Increased awareness 
of A. cantonensis infection in humans is needed among 
healthcare providers.
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University of Texas Health, McGovern Medical School. Her 
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Figure. Magnetic resonance imaging (MRI) of the brain (A)  
and the spine (B) showing meningitis and myelitis in a 12-month-
old girl with Angiostrongylus cantonensis infection, Houston, 
Texas, USA. A) Axial T1 post contrast sequences showing diffuse 
leptomeningeal enhancement (arrows). B) Sagittal T1 postcontrast 
sequences showing intramedullary enhancement in the thoracic 
and lumbar spinal cord T8–L5 with diffuse leptomeningeal 
enhancement (arrows).
